Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03753659 |
|---|---|
| Brief Title: | IMMULAB - Immunotherapy With Pembrolizumab in Combination With Local Ablation in Hepatocellular Carcinoma (HCC) |
| First Submitted : | November 19, 2018 |
| First Submitted that Met QC Criteria : | November 22, 2018 |
| First Posted : | November 27, 2018 |
| Last Update Submitted that Met QC Criteria : | November 10, 2022 |
| Last Update Posted : | November 14, 2022 |